Associations between COVID-19 therapies and inpatient gastrointestinal bleeding: A multisite retrospective study.

导出 OA

翻译打印收藏纠错

作者： Noah A,Wiedel ^[1] ; Harlan,Sayles ^[2] ; Jessica,Larson ^[3] ; Jana L,Wardian ^[1] ; Alexander,Hewlett ^[4] ; James,McClay ^[5] ; Jin,Ge ^[6] ; Alfred Jerrod,Anzalone ^[7] ; N3C consortium

作者单位： Department of Internal Medicine, Division of Hospital Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA. ^[1] Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska, USA. ^[2] Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA. ^[3] Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, Nebraska, USA. ^[4] Department of Health Management & Informatics, University of Missouri School of Medicine, Columbia, Missouri, USA. ^[5] Department of Medicine, Division of Gastroenterology and Hepatology, University of California at San Francisco, San Francisco, California, USA. ^[6] Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska, USA. ^[7]

关键词 COVID-19 GI bleeding dexamethasone remdesivir